CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) Institutional Ownership

13F Institutional Holders and Ownership History from Q1 2014 to Q4 2025

Type / Class
Equity / Common Stock
Symbol
CRL on NYSE
Shares outstanding
49,020,909
Price per share
$218.99
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
52,777,987
Total reported value
$10,536,556,980
% of total 13F portfolios
0.01%
Share change
+2,684,528
Value change
+$592,488,346
Number of holders
567
Price from insider filings
$218.99
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 6.9% $405,588,067 3,524,401 BlackRock, Inc. 31 Mar 2025
Invesco Ltd. 5.5% $590,429,888 2,696,150 Invesco Ltd. 31 Dec 2025
WELLINGTON MANAGEMENT GROUP LLP 3.6% -41% $383,060,155 -$315,620,213 1,749,213 -45% Wellington Management Group LLP 31 Dec 2025
NOMURA HOLDINGS INC 1.6% -76% $126,407,633 -$293,166,299 807,923 -70% NOMURA HOLDINGS INC 30 Sep 2025

As of 31 Dec 2025, 567 institutional investors reported holding 52,777,987 shares of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL). This represents 108% of the company’s total 49,020,909 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) together control 75% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
VANGUARD GROUP INC 12% 5,887,175 +0.81% 0.02% $1,174,373,670
BlackRock, Inc. 7.7% 3,754,354 -2.6% 0.01% $748,918,482
Invesco Ltd. 5.5% 2,696,150 +116% 0.08% $537,828,003
Allspring Global Investments Holdings, LLC 4.1% 1,995,596 -8.4% 0.65% $403,948,542
STATE STREET CORP 3.8% 1,871,688 +2.2% 0.01% $373,364,322
WELLINGTON MANAGEMENT GROUP LLP 3.6% 1,749,213 -45% 0.06% $348,933,009
FMR LLC 3.5% 1,733,910 +319% 0.02% $345,880,201
HARRIS ASSOCIATES L P 3.4% 1,677,606 +14% 0.42% $334,648,845
DIMENSIONAL FUND ADVISORS LP 2.9% 1,442,224 +28% 0.06% $287,702,677
ARIEL INVESTMENTS, LLC 2.9% 1,427,771 -4.2% 3.1% $284,811,759
AMERIPRISE FINANCIAL INC 2.8% 1,384,383 +126% 0.06% $276,157,008
GEODE CAPITAL MANAGEMENT, LLC 2.6% 1,276,502 +0.77% 0.02% $254,185,865
BANK OF AMERICA CORP /DE/ 2.2% 1,080,527 -7.1% 0.02% $215,543,526
EARNEST PARTNERS LLC 2% 988,259 -1.8% 0.84% $197,137,905
MASSACHUSETTS FINANCIAL SERVICES CO /MA/ 1.8% 884,691 0.06% $176,478,161
NEUBERGER BERMAN GROUP LLC 1.8% 860,158 +1.3% 0.13% $171,606,050
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.7% 836,240 +8.7% 0.1% $166,813,155
MORGAN STANLEY 1.6% 792,820 -5% 0.01% $158,152,120
MACKENZIE FINANCIAL CORP 1.6% 781,476 -21% 0.19% $157,531,990
SEI INVESTMENTS CO 1.5% 756,758 +0.94% 0.15% $150,961,985
VICTORY CAPITAL MANAGEMENT INC 1.4% 691,474 +9939% 0.08% $137,935,234
Alyeska Investment Group, L.P. 1.3% 644,726 +121% 0.36% $128,609,942
COOKE & BIELER LP 1.2% 607,565 +0.61% 1.3% $121,197,066
Clearbridge Investments, LLC 1% 511,618 +23% 0.08% $102,057,559
NORGES BANK 0.99% 485,087 0.01% $96,765,155

Institutional Holders of CHARLES RIVER LABORATORIES INTERNATIONAL, INC. - Common Stock (CRL) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 52,777,987 $10,536,556,980 +$592,488,346 $199.48 567
2025 Q3 50,358,962 $7,914,672,575 -$81,951,872 $156.46 548
2025 Q2 50,888,032 $7,728,322,181 -$310,858,917 $151.73 512
2025 Q1 52,969,373 $7,965,191,033 -$132,450,866 $150.52 556
2024 Q4 52,965,520 $9,772,547,065 +$141,580,661 $184.60 629
2024 Q3 51,997,508 $10,237,704,172 +$106,573,857 $196.97 620
2024 Q2 52,315,867 $10,806,083,788 -$50,431,113 $206.58 652
2024 Q1 52,068,409 $14,099,205,526 +$83,751,736 $270.95 663
2023 Q4 51,907,726 $12,262,886,096 +$33,773,620 $236.40 626
2023 Q3 51,730,793 $10,129,283,110 +$137,477,111 $195.98 613
2023 Q2 51,052,211 $10,727,150,937 +$46,431,278 $210.25 606
2023 Q1 50,855,208 $10,257,550,518 +$230,104,905 $201.82 610
2022 Q4 49,950,724 $10,886,200,761 -$62,906,975 $217.90 616
2022 Q3 50,414,076 $9,921,902,851 +$280,780,236 $196.80 566
2022 Q2 48,746,360 $10,430,287,913 +$210,876,421 $213.97 612
2022 Q1 47,548,656 $13,504,739,634 +$68,014,953 $283.97 631
2021 Q4 47,053,533 $17,719,824,151 +$122,176,357 $376.78 696
2021 Q3 46,743,700 $19,292,102,147 -$322,317,303 $412.67 663
2021 Q2 47,485,940 $17,565,553,473 +$159,923,840 $369.92 626
2021 Q1 47,155,221 $13,665,037,431 +$124,076,612 $289.83 555
2020 Q4 46,852,548 $11,705,651,069 +$64,724,684 $249.86 533
2020 Q3 46,655,777 $10,562,682,947 +$28,508,177 $226.45 487
2020 Q2 50,866,401 $8,795,028,070 +$54,062,078 $174.35 457
2020 Q1 46,418,204 $5,859,212,569 -$77,502,036 $126.21 405
2019 Q4 46,958,559 $7,173,472,632 +$23,088,239 $152.76 403
2019 Q3 46,979,015 $6,218,760,306 +$100,248,974 $132.37 391
2019 Q2 46,156,461 $6,548,651,561 +$43,618,455 $141.90 398
2019 Q1 46,207,583 $6,703,515,424 +$124,731,562 $145.25 402
2018 Q4 45,431,938 $5,145,292,255 -$151,345,177 $113.18 401
2018 Q3 46,643,770 $6,271,366,247 +$95,417,101 $134.54 364
2018 Q2 46,298,815 $5,194,961,361 -$89,035,927 $112.26 345
2018 Q1 47,194,179 $5,032,045,297 +$8,653,634 $106.74 331
2017 Q4 47,238,705 $5,163,116,710 +$107,882,172 $109.45 338
2017 Q3 45,920,035 $4,960,436,852 -$9,151,703 $108.02 333
2017 Q2 45,975,742 $4,650,100,775 -$46,154,434 $101.15 300
2017 Q1 46,707,818 $4,201,206,531 +$352,124,245 $89.95 296
2016 Q4 46,202,771 $3,520,468,018 -$21,735,248 $76.19 294
2016 Q3 46,166,065 $3,844,365,949 +$20,498,550 $83.34 280
2016 Q2 46,125,327 $3,804,330,076 -$34,946,309 $82.44 279
2016 Q1 46,964,049 $3,568,493,897 +$146,096,438 $75.94 261
2015 Q4 45,023,951 $3,619,495,201 -$42,314,902 $80.39 263
2015 Q3 46,043,732 $2,924,569,828 -$38,255,873 $63.52 255
2015 Q2 46,642,392 $3,280,937,734 -$17,951,808 $70.34 259
2015 Q1 46,816,382 $3,709,872,590 +$59,266,038 $79.29 257
2014 Q4 46,271,208 $2,946,620,531 +$20,379,643 $63.64 250
2014 Q3 46,698,782 $2,789,816,513 -$86,471,529 $59.74 254
2014 Q2 48,221,369 $2,580,806,262 -$17,325,131 $53.52 260
2014 Q1 48,069,607 $2,899,195,114 +$73,553,910 $60.34 257